EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieOpen Access · CC BY-NC 4.0

Real‐World Unmet Needs of Patients With Haemophilia A and Haemophilia B With or Without Inhibitors: End‐of‐Study Results From the explorer6 Non‐Interventional Study

Allison P Wheeler iD, Aby Abraham, Chris Barnes, Renée Brown Frandsen, Roseline d'Oiron iD, Hermann Eichler iD, Kingsley Hampton iD, Francisco José López-Jaime, Chuhl Joo Lyu, Camila Martins Mazini Tavares, Keiji Nogami iD, Christopher Sutton und 3 weitere

Haemophilia · 2025-09 · 31 (5) · 903-911

DOI: 10.1111/hae.70051 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Haemophilia, online erschienen am 05.05.2025. Verfasst von Allison P Wheeler und 14 weiteren Autor:innen. Beteiligte Einrichtung: Washington Centre for Bleeding Disorders, Seattle, Washington, USA. Hauptthemen laut MEDLINE: Hemophilia A, Hemophilia B. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Novo Nordisk A/S.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Haemophilia is associated with high disease and treatment burdens. Prospective evaluation of data from patients with haemophilia helps understand and define unmet needs, optimise treatment and improve healthcare outcomes.

Aim

To present end‐of‐study data from explorer6 (NCT03741881), a prospective, non‐interventional study across multiple countries in patients with haemophilia (haemophilia A or B without [HA or HB] or with inhibitors [HAwI or HBwI]).

Methods

Patients ≥12 years old with severe HA, severe/moderate HB or HAwI/HBwI of any severity were treated according to the local standard of care (SoC). The number of bleeding episodes from enrolment up to a maximum of 115 weeks, physical activity based on data collected by a wrist‐worn physical activity tracker, target joints and Haemophilia Joint Health Score (HJHS) measurements were assessed.

Results

A total of 231 patients across 33 countries were enrolled. The mean annualised bleeding rate (ABR) (standard deviation) for treated bleeding episodes was investigated for patients receiving prophylaxis (HA: 4.7 [5.9]; HB: 2.2 [3.0]; HAwI: 10.3 [8.5]; HBwI: 12.4 [14.1]) and those receiving on‐demand (OnD) treatment (HA: 21.5 [17.7]; HB: 10.5 [8.6]; HAwI: 15.2 [14.8]; HBwI: 9.3 [13.3]). Physical activity levels were lowest among patients with HBwI. Target joints were similar among haemophilia types and treatments. Overall, mean and median HJHS total scores were lower for patients receiving prophylaxis compared with OnD treatment.

Conclusion

The explorer6 study assessed a large haemophilia patient population in a real‐world setting across 33 countries. The results indicate that an unmet need remains among patients receiving OnD treatment and those with inhibitors. Trial Registration : ClinicalTrials.gov identifier: NCT03741881

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hemophilia AHemophilia BAdolescentAdultFemaleHumansMaleMiddle AgedYoung AdultHemorrhageProspective Studies

Stichwörter der Autor:innen

anti‐tissue factor pathway inhibitor (TFPI)factor VIIIhaemophiliaprophylaxistreatment burden

Autor:innen und Institutionen

  • Washington Centre for Bleeding Disorders, Seattle, Washington, USA.
  • University of Washington Department of Haematology, Seattle, Washington, USA.
  • Department of Haematology, Christian Medical College, Vellore, India.
  • The Royal Children's Hospital, Melbourne, VIC, Australia.
  • Novo Nordisk A/S, Søborg, Denmark.
  • Centre de Référence de l'Hémophilie et de Maladies Hémorragiques Rares, Hôpital Bicêtre AP-HP and INSERM Hémostase inflammation thrombose HITH U1176, Université Paris-Saclay, Le Kremlin-Bicêtre, France.

ORCID-Profile: Allison P Wheeler, Roseline d'Oiron, Hermann Eichler, Kingsley Hampton, Keiji Nogami, Bulent Zulfikar, Giancarlo Castaman

Förderung

  • Novo Nordisk A/S

Zitieren

APA

Wheeler, A. P., Abraham, A., Barnes, C., Brown Frandsen, R., d'Oiron, R., Eichler, H., Hampton, K., López-Jaime, F. J., Lyu, C. J., Tavares, C. M. M., Nogami, K., Sutton, C., Windyga, J., Zulfikar, B., & Castaman, G. (2025). Real‐World Unmet Needs of Patients With Haemophilia A and Haemophilia B With or Without Inhibitors: End‐of‐Study Results From the explorer6 Non‐Interventional Study. Haemophilia, 31(5), 903-911. https://doi.org/10.1111/hae.70051

Vancouver

Wheeler AP, Abraham A, Barnes C, Brown Frandsen R, d'Oiron R, Eichler H, et al. Real‐World Unmet Needs of Patients With Haemophilia A and Haemophilia B With or Without Inhibitors: End‐of‐Study Results From the explorer6 Non‐Interventional Study. Haemophilia. 2025;31(5):903-911. doi:10.1111/hae.70051

BibTeX
@article{Wheeler2025,
  author = {Wheeler, Allison P and Abraham, Aby and Barnes, Chris and Brown Frandsen, Renée and d'Oiron, Roseline and Eichler, Hermann and Hampton, Kingsley and López-Jaime, Francisco José and Lyu, Chuhl Joo and Tavares, Camila Martins Mazini and Nogami, Keiji and Sutton, Christopher and Windyga, Jerzy and Zulfikar, Bulent and Castaman, Giancarlo},
  title = {Real‐World Unmet Needs of Patients With Haemophilia A and Haemophilia B With or Without Inhibitors: End‐of‐Study Results From the explorer6 Non‐Interventional Study},
  journal = {Haemophilia},
  year = {2025},
  volume = {31},
  number = {5},
  pages = {903--911},
  doi = {10.1111/hae.70051}
}
Kostenlos starten →